Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$865000.00
↑ 101% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-80.93M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $865000.00 | +100.6% |
| 2024 | $-148.99M | -18.9% |
| 2023 | $-125.33M | +47.5% |
| 2022 | $-238.64M | -8191.8% |
| 2021 | $-2.88M | +96.9% |
| 2020 | $-94.20M | -21.5% |
| 2019 | $-77.52M | -19.6% |
| 2018 | $-64.79M | +19.2% |
| 2017 | $-80.20M | -457.6% |
| 2016 | $22.43M | - |